The Pharmaceutical Care Management Association (PCMA), the trade association representing pharmacy benefit managers (PBMs), hired Emergent Strategies to lobby on issues related to the industry. PBMs have been under tremendous pressure from lawmakers, pharmaceutical groups and others who argue they drive up prescription drug prices and demand transparency into their opaque operations.
The PCMA has been at the forefront of pushing back on those claims and engaging with lawmakers on a slate of bills that could reform the industry. Its federal lobbying spending skyrocketed to $15.4 million last year from $8.7 million in 2022, according to the nonpartisan political money tracking organization OpenSecrets.
Scott Eckhart, the former lead Democratic lobbyist at the U.S. Chamber of Commerce, will work on the account.
https://thehill.com/lobbying/4749654-bottom-line-pbms-plus-up/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.